“HMG COA REDUCTASE INHIBITING COMPOSIITON
Application 1249/MUM/2003 published 2006-06-16, filed 2003-12-05
The present invention relates to a HMG CoA Reductase inhibiting composition with improved bioavailability. The present invention also relates to a method for preparation of such composition and to the competitive inhibition of HMG CoA Reductase using such composition. The active ingredients are present in a rapidly dissolvable and more solubilized state, thereby enabling sustained and complete solubilizaiton, more rapid dissolution upon administration to a patient, improved absorption and/or bioavailability and also increased flexibility in terms of providing the active ingredient and being capable of administration in the form of a solution, suspension, solid dispersion, solid solution or semi-solid formulation. Drawing: NIL Total Pages: 19 Fig. Nil
Applicant
CADILA HEALTHCARE LTD.
ZYDUS TOWER, SATELLITE CROSS ROADS, AHMEDABAD 380 015, GUJARAT, INDIA
Inventor
1. VENKATARAM SURESH 2. MAHESH B.K. 3. RAMAKRISHNA N.V.S
International Info
Classification: C08L 61/00